
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>103-210</title>
    </head>

    <body>
        <h1>
        <a href="./103_209.html" rel="external" title="prev">≪</a>
        103-210
        <a href="./103_211.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p>6歳男児。体重20kg。身長120cm。扁桃炎と診断され、この男児の処方箋を、母親が薬局に持参した(処方1)。</p>
<p><img alt="" class="alignnone size-full wp-image-3209" height="74.89999999999999" loading="lazy" sizes="(max-width: 619px) 100vw, 619px" src="data:;base64,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" width="433.29999999999995"/></p>
<p>セフジニル細粒10%の添付文書には、「通常、小児に対してセフジニルとして1日量9～18mg(力価)/kgを3回に分割して経口投与する」と記載されている。</p>
<p>お薬手帳を確認したところ、男児は鉄欠乏性貧血で溶性ピロリン酸第二鉄を服用していることが判明した(処方2)。</p>
<p><img alt="" class="alignnone size-full wp-image-3207" height="72.1" loading="lazy" sizes="(max-width: 624px) 100vw, 624px" src="data:;base64,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" width="436.79999999999995"/></p>
<h4>問210</h4>
<p>セフジニルは鉄イオンに配位し、キレートを形成する。矢印で示したセフジニルの原子のうち、鉄イオンに最も配位しにくいのはどれか。1つ選べ。</p>
<p><img alt="" class="alignnone size-full wp-image-3215" height="196.7" loading="lazy" sizes="(max-width: 462px) 100vw, 462px" src="data:;base64,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" width="323.4"/></p>
<h4>問211</h4>
<p>本症例に対し、薬剤師が行う対応の中で適切なのはどれか。2つ選べ。</p>
<ol><li>セフジニル細粒10%の投与量について医師に疑義照会する。</li><li>セフジニル細粒10%からレボフロキサシン水和物製剤への処方変更を医師に提案する。</li><li>セフジニル細粒10%は鉄剤と一緒に服用するように指導する。</li><li>症状が途中で改善したら服用を終了するように指導する。</li><li>尿や便が赤色調を呈することがあると説明する。</li></ol>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            問210：4問211：1, 5
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <h4>問210</h4>
<p><span style="font-weight: 400;">アミド結合の N は塩基性が低く、</span><span style="font-weight: 400;">最も配位しづらいと考えられます。</span><span style="font-weight: 400;">よって、正解は 4 です。</span></p>
<h4>問211</h4>
<p><span style="font-weight: 400;">選択肢 1 は、</span><span style="font-weight: 400;">適切な記述と考えられます。</span><span style="font-weight: 400;">セフジニルと鉄のキレート形成により</span><span style="font-weight: 400;">吸収が低下するため、この投与量では</span><span style="font-weight: 400;">適切な薬効が期待できない、という点から</span><span style="font-weight: 400;">疑義照会する　という対応です。</span></p>
<p><span style="font-weight: 400;">選択肢 2 ですが<br/></span><span style="font-weight: 400;">レボフロキサシンも鉄とのキレートを形成します。</span><span style="font-weight: 400;">よって、選択肢 2 は誤りです。</span></p>
<p><span style="font-weight: 400;">選択肢 3 ですが<br/></span><span style="font-weight: 400;">キレート形成を避けるため、</span><span style="font-weight: 400;">服用時期を「ずらすよう」指導すべきです。</span><span style="font-weight: 400;">「一緒に服用」ではありません。</span><span style="font-weight: 400;">よって、選択肢 3 は誤りです。</span></p>
<p><span style="font-weight: 400;">選択肢 4 ですが<br/></span><span style="font-weight: 400;">耐性菌の発生を避けるため、</span><span style="font-weight: 400;">症状が改善しても５日分飲み切るように</span><span style="font-weight: 400;">指導します。</span><span style="font-weight: 400;">よって、選択肢 4 は誤りです。</span></p>
<p><span style="font-weight: 400;">選択肢 5 は、正しい記述です。<br/></span><span style="font-weight: 400;">代謝物により、色がつくことがあります。</span></p>
<p><span style="font-weight: 400;">以上より、正解は 1,5 です。</span></p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    